Tasigna Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Alerts
• Clinical Trials

Impact of Nilotinib on Safety, Tolerability, Pharmacokinetics and Biomarkers in Dementia With Lewy Bodies
Condition:   Dementia With Lewy Bodies Interventions:   Drug: Placebo oral capsule;   Drug: Nilotinib Oral Capsule Sponsors:   Georgetown University;   National Institutes of Health (NIH) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 28, 2019 Category: Research Source Type: clinical trials